Ambeed.cn

首页 / 抑制剂/激动剂 / 神经信号通路 / S100β / Arundic Acid

(R)-2-丙基辛酸 /Arundic Acid

货号:A621199 同义名: ONO-2506;(R)-2-Propyloctanoic acid

Arundic acid (ONO-2506) 是一种星形胶质细胞调节剂,可抑制 S-100β 的合成,通过调节星形胶质细胞的激活来延缓脑梗塞的扩展。Arundic acid 具有用于中风和阿尔茨海默病研究的潜力。

Arundic Acid 化学结构 CAS号:185517-21-9
Arundic Acid 化学结构
CAS号:185517-21-9
Arundic Acid 3D分子结构
CAS号:185517-21-9
Arundic Acid 化学结构 CAS号:185517-21-9
Arundic Acid 3D分子结构 CAS号:185517-21-9
规格 价格 库存 数量
购物车 收藏 询单

Arundic Acid 纯度/质量文件 产品仅供科研

货号:A621199 标准纯度:
批次查询: 批次纯度:

全球学术期刊中引用的产品

ACS Appl. Nano Mater., 2025. Ambeed. [ A188026 ]
Eur. J. Clin. Microbiol. Infect. Dis., 2025. Ambeed. [ A151161 ]
JJC, 2025, 20(Special Issue)): 27-39. Ambeed. [ A713856 ]
bioRxiv, 2025. Ambeed. [ A538667 , A714873 , A126729 , A126049 , A446054 ]
Nature Communications, 2025, 16, 1871. Ambeed. [ A508148 ]
更多 >

Arundic Acid 生物活性

描述 ONO-2506 is an astrocyte-modulating agent that suppresses astrocyte activation via inhibiting the synthesis of S-100β and thereby delaying the expansion of cerebral infarcts. It exhibits therapeutic potential for stroke and Alzheimer’s disease[1]. ONO-2506 at concentrations between 30 to 300mmol/L significantly inhibited the mRNA expression and decreased the intracellular levels of S-100β. Repeated intravenous injection with ONO-2506 (50mg/kg) for 4 weeks induced inflammatory responses at the injection site and transient ataxic gait in both rats and dogs[3]. In a mouse model of MPTP-induced Parkinson’s disease, treatment with ONO-2506 (30mg/kg, i.p.) at 1min, 6h, 24h, 48h, and 72h after the last MPTP injection prevented dopamine depletion and the appearance of motor abnormalities in behavioral tests. Compared to mice injected with MPTP alone, ONO-2506 administration increased tyrosine hydroxylase-containing dopaminergic neurons in the substantia nigra (87% reduction vs. 56% reduction). ONO-2506 treatment also induced an earlier appearance of reactive astrocytes by three days and suppressed the expression of S-100β in MPTP-injected mice[4].

Arundic Acid 参考文献

[1]Haasegawa, T., Kawanaka, Y., Kasamatsu, E. et al. Process Development of ONO-2506:  A Therapeutic Agent for Stroke and Alzheimer's Disease. Org. Proc. Res. Dev. 2003, 7((2): 168-171.

[2]Kato H, et al. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTPneurotoxicity in mice. Brain Res. 2004 Dec 24;1030(1):66-73.

[3]Asano T, Mori T, Shimoda T, et al. Arundic acid (ONO-2506) ameliorates delayed ischemic brain damage by preventing astrocytic overproduction of S100B. Curr Drug Targets CNS Neurol Disord. 2005;4(2):127-142.

[4]Kato H, Kurosaki R, Oki C, Araki T. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice. Brain Res. 2004;1030(1):66-73.

Arundic Acid 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.37mL

1.07mL

0.54mL

26.84mL

5.37mL

2.68mL

53.68mL

10.74mL

5.37mL

Arundic Acid 技术信息

CAS号185517-21-9
分子式C11H22O2
分子量 186.291
别名 ONO-2506;(R)-2-Propyloctanoic acid;Proglia;ONO-2506PO;MK-0724;Cereact;Arocyte
运输蓝冰
存储条件

In solvent -20°C:3-6个月-80°C:12个月

溶解方案

DMSO: 145 mg/mL(778.35 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案一
方案二
动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。